Radius Ventures

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Healthsense, Inc. specializes in remote monitoring services aimed at the senior care continuum. Founded in 2001 and based in Mendota Heights, Minnesota, the company provides health and safety monitoring solutions that track essential daily activities such as eating, sleeping, and movement. Their technology includes analytics that transform data into actionable insights, a centralized dashboard for caregivers, health notes to alert changes in behavior, and real-time notifications for urgent needs. These features help caregivers respond effectively to the needs of seniors, enhancing their independence and overall quality of life. Healthsense serves various markets, including senior living, managed care, and home care, and operates as a subsidiary of GreatCall, Inc. since December 2016.

MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Impliant Ltd. and over $50 million have been invested in laboratory testing and clinical work to perfect the implant, the instrumentation, and the surgical technique. The TOPS(TM) System aims to revolutionize the spinal implant market in much the same way that total hip and total knee replacement systems displaced hip and knee fusions. Premia Spine's singular focus today is to provide patients and surgeons with a clinically-proven superior solution to lumbar fusion surgery.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

CareKinesis, Inc. provides state-of-the-art medication management through a combination of technology, science and services that reduces costs, improves the quality of care and decreases the risks associated with ineffective medication plans.

MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.

Healthsense, Inc. specializes in remote monitoring services aimed at the senior care continuum. Founded in 2001 and based in Mendota Heights, Minnesota, the company provides health and safety monitoring solutions that track essential daily activities such as eating, sleeping, and movement. Their technology includes analytics that transform data into actionable insights, a centralized dashboard for caregivers, health notes to alert changes in behavior, and real-time notifications for urgent needs. These features help caregivers respond effectively to the needs of seniors, enhancing their independence and overall quality of life. Healthsense serves various markets, including senior living, managed care, and home care, and operates as a subsidiary of GreatCall, Inc. since December 2016.

Ambit Biosciences is a privately-held biopharmaceutical company dedicated to the discovery and development of small molecule kinase inhibitors aimed at treating cancer, inflammatory diseases, and other conditions. The company's lead compound, AC220, is a selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various indications. The clinical pipeline also includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. In addition, Ambit has several preclinical candidates, including CEP-32496, a BRAF inhibitor that has been licensed to Cephalon. Through its innovative research, Ambit aims to improve treatment outcomes for patients suffering from cancer.

Tactile Medical is a medical technology company based in Minneapolis, Minnesota, focused on developing and providing innovative devices for the treatment of chronic diseases, particularly lymphedema and venous disorders. The company offers several key products, including the Flexitouch Plus system, a pneumatic compression device designed for at-home treatment of lymphedema, and the Entré System, which provides portable compression therapy for conditions such as chronic venous insufficiency and venous leg ulcers. Additionally, Tactile Medical markets the ACTitouch system for managing chronic venous insufficiency and the Airwear Gradient Compression Wrap, known as Aero-Wrap, to assist in the treatment of venous hypertension and lymphedema. Founded in 1995, Tactile Medical aims to improve the standard of care for patients managing these chronic conditions in a home setting.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

Ambit Biosciences is a privately-held biopharmaceutical company dedicated to the discovery and development of small molecule kinase inhibitors aimed at treating cancer, inflammatory diseases, and other conditions. The company's lead compound, AC220, is a selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various indications. The clinical pipeline also includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. In addition, Ambit has several preclinical candidates, including CEP-32496, a BRAF inhibitor that has been licensed to Cephalon. Through its innovative research, Ambit aims to improve treatment outcomes for patients suffering from cancer.

USystems specializes in the design, development, and manufacturing of advanced technology solutions in two primary sectors: medical imaging and data center infrastructure. In the medical field, the company creates innovative breast ultrasound systems that aid radiologists in detecting breast cancer, particularly in women with dense breast tissue, by providing detailed 3D ultrasound images for improved visualization. In the realm of data centers, USystems manufactures cooling systems that enhance sustainability while reducing noise and heat. Their offerings include air-cooled and soundproof rapid deployment micro data centers equipped with intelligent features, such as real-time alarms and optional security monitoring, to safeguard IT equipment and optimize operational efficiency. Through its cutting-edge designs and state-of-the-art manufacturing processes, USystems is committed to delivering high-quality solutions that address critical challenges in both healthcare and information technology.

USystems specializes in the design, development, and manufacturing of advanced technology solutions in two primary sectors: medical imaging and data center infrastructure. In the medical field, the company creates innovative breast ultrasound systems that aid radiologists in detecting breast cancer, particularly in women with dense breast tissue, by providing detailed 3D ultrasound images for improved visualization. In the realm of data centers, USystems manufactures cooling systems that enhance sustainability while reducing noise and heat. Their offerings include air-cooled and soundproof rapid deployment micro data centers equipped with intelligent features, such as real-time alarms and optional security monitoring, to safeguard IT equipment and optimize operational efficiency. Through its cutting-edge designs and state-of-the-art manufacturing processes, USystems is committed to delivering high-quality solutions that address critical challenges in both healthcare and information technology.

EndoGastric Solutions, Inc. is a medical device company focused on developing and commercializing innovative surgical technologies for the treatment of gastrointestinal diseases, particularly gastroesophageal reflux disease (GERD). The company is known for its Transoral Incisionless Fundoplication (TIF®) procedure, which provides a minimally invasive alternative to traditional surgical methods by allowing treatment without external incisions. Key products include the EsophyX technology, which facilitates transoral reconstructive surgery, and the SerosaFuse Fasteners, designed for secure tissue attachment. Additionally, EndoGastric Solutions offers training courses for surgeons and a range of consultative support services. Founded in 2002 and headquartered in Redmond, Washington, the company also has an office in San Mateo, California.

Healthsense, Inc. specializes in remote monitoring services aimed at the senior care continuum. Founded in 2001 and based in Mendota Heights, Minnesota, the company provides health and safety monitoring solutions that track essential daily activities such as eating, sleeping, and movement. Their technology includes analytics that transform data into actionable insights, a centralized dashboard for caregivers, health notes to alert changes in behavior, and real-time notifications for urgent needs. These features help caregivers respond effectively to the needs of seniors, enhancing their independence and overall quality of life. Healthsense serves various markets, including senior living, managed care, and home care, and operates as a subsidiary of GreatCall, Inc. since December 2016.

Management Health Solutions, Inc. (MHS) is a prominent provider of integrated inventory management solutions tailored for hospitals and healthcare systems in North America. Established in 1999 and headquartered in Fairfield, Connecticut, MHS focuses on reducing clinical supply inventory costs while streamlining supply chain operations. The company enhances patient safety and financial performance through a combination of professional services, content solutions, benchmarks, advanced technology, and mobile device management. By implementing its solutions, MHS helps healthcare organizations achieve measurable returns on investment, ultimately contributing to more efficient and effective clinical supply management.

Heartscape Technologies, Inc. develops and markets medical devices for hospitals in the United States. The company offers PRIME ECG System, a cardiac diagnostic system designed to diagnose heart attacks and ischemia. Its PRIME ECG System displays a range of images that allows a physician to detect potential problem areas and explore important details needed for diagnosis; and various test reports.

Medingo develops and produces miniature medical devices for people with diabetes. The company's flagship product is the Solo MicroPump, a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or needles. The company was founded in 2005 and is based in Yoqneam Illit, Israel and the US Corporate Office is in Tampa, FL.

Ambit Biosciences is a privately-held biopharmaceutical company dedicated to the discovery and development of small molecule kinase inhibitors aimed at treating cancer, inflammatory diseases, and other conditions. The company's lead compound, AC220, is a selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor currently undergoing clinical trials for patients with relapsed or refractory acute myeloid leukemia (AML). Ambit is collaborating with Astellas Pharma Inc. to jointly develop and commercialize FLT3 kinase inhibitors across various indications. The clinical pipeline also includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor. In addition, Ambit has several preclinical candidates, including CEP-32496, a BRAF inhibitor that has been licensed to Cephalon. Through its innovative research, Ambit aims to improve treatment outcomes for patients suffering from cancer.

USystems specializes in the design, development, and manufacturing of advanced technology solutions in two primary sectors: medical imaging and data center infrastructure. In the medical field, the company creates innovative breast ultrasound systems that aid radiologists in detecting breast cancer, particularly in women with dense breast tissue, by providing detailed 3D ultrasound images for improved visualization. In the realm of data centers, USystems manufactures cooling systems that enhance sustainability while reducing noise and heat. Their offerings include air-cooled and soundproof rapid deployment micro data centers equipped with intelligent features, such as real-time alarms and optional security monitoring, to safeguard IT equipment and optimize operational efficiency. Through its cutting-edge designs and state-of-the-art manufacturing processes, USystems is committed to delivering high-quality solutions that address critical challenges in both healthcare and information technology.

USystems specializes in the design, development, and manufacturing of advanced technology solutions in two primary sectors: medical imaging and data center infrastructure. In the medical field, the company creates innovative breast ultrasound systems that aid radiologists in detecting breast cancer, particularly in women with dense breast tissue, by providing detailed 3D ultrasound images for improved visualization. In the realm of data centers, USystems manufactures cooling systems that enhance sustainability while reducing noise and heat. Their offerings include air-cooled and soundproof rapid deployment micro data centers equipped with intelligent features, such as real-time alarms and optional security monitoring, to safeguard IT equipment and optimize operational efficiency. Through its cutting-edge designs and state-of-the-art manufacturing processes, USystems is committed to delivering high-quality solutions that address critical challenges in both healthcare and information technology.

Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life. The product development portfolio of the Company includes MultiStem, a stem cell product, which is being developed as a treatment for multiple disease indications, and is being evaluated in two ongoing clinical trials, and has been authorized for use in a third clinical trial. In addition, the Company is developing pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, and narcolepsy or other forms of excessive daytime sleepiness.

BioStorage Technologies, Inc. is a global provider of sample management solutions tailored for the bioscience industry. Established in 2002 and headquartered in Indianapolis, Indiana, the company offers a range of services including consulting, logistics, storage, and preparation of biological samples. It serves a diverse clientele, including pharmaceutical and biotech firms, donor organizations, and academic institutions. The company operates biorepository facilities in both Indianapolis and Griesheim, Germany, ensuring temperature-controlled storage and comprehensive sample lifecycle management. BioStorage Technologies employs a team of experts and utilizes a real-time, web-based tracking system to enhance operational efficiency. Through strategic partnerships with organizations such as ELPRO and FedEx, the company aims to set industry standards in service quality and value. As of 2015, BioStorage Technologies operates as a subsidiary of Brooks Automation, Inc.

Heartscape Technologies, Inc. develops and markets medical devices for hospitals in the United States. The company offers PRIME ECG System, a cardiac diagnostic system designed to diagnose heart attacks and ischemia. Its PRIME ECG System displays a range of images that allows a physician to detect potential problem areas and explore important details needed for diagnosis; and various test reports.

Targanta Therapeutics is a biopharmaceutical company dedicated to the development and commercialization of innovative antibiotics aimed at treating serious infections encountered in hospitals and institutional settings. The company focuses on addressing gram-positive bacterial infections, particularly complicated skin and skin structure infections. By concentrating on these critical areas, Targanta Therapeutics seeks to enhance the efficacy of treatment options available for healthcare providers managing severe infections.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Heartscape Technologies, Inc. develops and markets medical devices for hospitals in the United States. The company offers PRIME ECG System, a cardiac diagnostic system designed to diagnose heart attacks and ischemia. Its PRIME ECG System displays a range of images that allows a physician to detect potential problem areas and explore important details needed for diagnosis; and various test reports.

Heartscape Technologies, Inc. develops and markets medical devices for hospitals in the United States. The company offers PRIME ECG System, a cardiac diagnostic system designed to diagnose heart attacks and ischemia. Its PRIME ECG System displays a range of images that allows a physician to detect potential problem areas and explore important details needed for diagnosis; and various test reports.

Heartscape Technologies, Inc. develops and markets medical devices for hospitals in the United States. The company offers PRIME ECG System, a cardiac diagnostic system designed to diagnose heart attacks and ischemia. Its PRIME ECG System displays a range of images that allows a physician to detect potential problem areas and explore important details needed for diagnosis; and various test reports.

Heartscape Technologies, Inc. develops and markets medical devices for hospitals in the United States. The company offers PRIME ECG System, a cardiac diagnostic system designed to diagnose heart attacks and ischemia. Its PRIME ECG System displays a range of images that allows a physician to detect potential problem areas and explore important details needed for diagnosis; and various test reports.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

EyeTel Imaging, founded in 1996, specializes in developing imaging technologies aimed at addressing vision loss caused by undetected diabetic retinopathy. The company signed a license agreement with Johns Hopkins University to commercialize new retinal imaging technology, leading to the creation of the EyeTel Retinal Imaging System, which is based on the DigiScope, a semi-automated fundus camera. This system enables the detection of various ocular conditions, including age-related macular degeneration and glaucoma. EyeTel also operates the EyeTel Reading Center, a telemedicine service that offers expert analysis of patient images. Collaborating with the Wilmer Eye Institute, EyeTel has ensured extensive clinical validation of its products. The company has established manufacturing partnerships to produce the DigiScope cost-effectively, and its enhancements have made the system a reliable diagnostic tool for optometrists.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.

Phylogix Inc. is a biotechnology company focused on tissue protection and oncology. The company develops lectin-based drugs focused on tissue protection, oncology, and immunology. It also involves in the development of FRIL, an agent to protect patients from the toxic side-effects of chemotherapy. Phylogix Inc. is based in Scarborough, Maine.

EyeTel Imaging, founded in 1996, specializes in developing imaging technologies aimed at addressing vision loss caused by undetected diabetic retinopathy. The company signed a license agreement with Johns Hopkins University to commercialize new retinal imaging technology, leading to the creation of the EyeTel Retinal Imaging System, which is based on the DigiScope, a semi-automated fundus camera. This system enables the detection of various ocular conditions, including age-related macular degeneration and glaucoma. EyeTel also operates the EyeTel Reading Center, a telemedicine service that offers expert analysis of patient images. Collaborating with the Wilmer Eye Institute, EyeTel has ensured extensive clinical validation of its products. The company has established manufacturing partnerships to produce the DigiScope cost-effectively, and its enhancements have made the system a reliable diagnostic tool for optometrists.

ZettaCore is at the forefront of molecular electronics, dedicated to creating advanced molecular materials tailored for the electronics industry. By utilizing innovative chemistry, the company enhances existing manufacturing processes, facilitating a shift towards improved performance while simultaneously reducing costs.

NuGEN Technologies, Inc. specializes in developing next-generation sequencing kits and genomic sample preparation reagents within the genomics sector. The company offers a range of DNA and RNA sample preparation products tailored for research and diagnostic applications. Its technologies support various genomic applications, including RNA-Seq, targeted resequencing, target capture, ChIP-Seq, and Methyl-Seq. NuGEN provides solutions for analyzing specimens that are limited or of poor quality, facilitating high-throughput applications across platforms such as Next Generation Sequencing and microarray analysis. Additionally, the company offers customer services, technical support, and tools for grants and publications. Founded in 2000 and based in San Carlos, California, NuGEN serves its customers through a network of distributors both domestically and internationally. As of September 2018, it operates as a subsidiary of Tecan Group Ltd.

Health Language specializes in enterprise terminology management solutions aimed at normalizing data across healthcare organizations. Founded in 2000 and based in Denver, Colorado, the company offers a suite of health management software, consulting services, and content that facilitates the mapping, translation, and management of clinical terminologies on a large scale. Its offerings include solutions for content standardization, data normalization, ICD-10 remediation, and enhanced workflows through streamlined search capabilities. By developing a proprietary middleware application, Health Language automates the integration of controlled medical vocabulary and coding standards into healthcare IT applications. This enables centralized access to medical terminology standards, promoting interoperability among hospitals, regions, and countries, and serving a diverse clientele that includes payers, providers, and vendors.

ZettaCore is at the forefront of molecular electronics, dedicated to creating advanced molecular materials tailored for the electronics industry. By utilizing innovative chemistry, the company enhances existing manufacturing processes, facilitating a shift towards improved performance while simultaneously reducing costs.

NuGEN Technologies, Inc. specializes in developing next-generation sequencing kits and genomic sample preparation reagents within the genomics sector. The company offers a range of DNA and RNA sample preparation products tailored for research and diagnostic applications. Its technologies support various genomic applications, including RNA-Seq, targeted resequencing, target capture, ChIP-Seq, and Methyl-Seq. NuGEN provides solutions for analyzing specimens that are limited or of poor quality, facilitating high-throughput applications across platforms such as Next Generation Sequencing and microarray analysis. Additionally, the company offers customer services, technical support, and tools for grants and publications. Founded in 2000 and based in San Carlos, California, NuGEN serves its customers through a network of distributors both domestically and internationally. As of September 2018, it operates as a subsidiary of Tecan Group Ltd.

TheScientificWorld is a scientific information portal that provides an integrated suite of scientific resources for scientists. The company was founded in 1997 and is headquartered in New York.

AMICAS, Inc. provides radiology, and medical image and information management solutions in the United States. Its AMICAS One Suite products provide an end-to-end IT solution for imaging centers, ambulatory care facilities, radiology practices, and billing services. The company offers AMICAS PACS, a Web-based picture archiving and communications system to capture, store, manipulate, and distribute diagnostic images for radiologists, specialists, referring physicians, patients, and healthcare enterprises; and AMICAS RIS, a Web-based radiology information system to capture radiology orders, detail the patient demographic information, schedule appointments and resources, process transcriptions, and generate reports, as well as to code and prepare billing and reimbursement data. It also provides AMICAS RadStream that offers integrated critical results management capabilities and document the communication of critical results reporting of radiology studies; AMICAS Documents, a module to capture, digitize, and associate paper records with digital information; and AMICAS Financials, which facilitates claims submission, payer follow-up, and other billing and accounts receivable management activities. In addition, the company offers AMICAS Reach, a Web-based tool that integrates the radiology report with key images; AMICAS Dashboards, a Web-based system that provides business intelligence capabilities; and AMICAS EDI offering transaction-based functions. Further, it provides professional and consulting services that assist its clients with a planned transition to a digital enterprise, as well as offers software and hardware support, implementation, training, and electronic data interchange services for patient billing and claims processing. The company was formerly known as VitalWorks Inc. and changed its name to AMICAS, Inc. in January 2005. AMICAS, Inc. was founded in 1989 and is headquartered in Boston, Massachusetts.